221 related articles for article (PubMed ID: 15559250)
1. Functional, molecular and pharmacological advances in 5-HT7 receptor research.
Hedlund PB; Sutcliffe JG
Trends Pharmacol Sci; 2004 Sep; 25(9):481-6. PubMed ID: 15559250
[TBL] [Abstract][Full Text] [Related]
2. 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern.
Hedlund PB; Huitron-Resendiz S; Henriksen SJ; Sutcliffe JG
Biol Psychiatry; 2005 Nov; 58(10):831-7. PubMed ID: 16018977
[TBL] [Abstract][Full Text] [Related]
3. The effects of photic and nonphotic stimuli in the 5-HT7 receptor knockout mouse.
Gardani M; Biello SM
Neuroscience; 2008 Mar; 152(1):245-53. PubMed ID: 18065150
[TBL] [Abstract][Full Text] [Related]
4. [Role of brain 5-HT7 receptors as a functional molecule involved in the development of stress adaptation].
Tsuji M; Takeuchi T; Miyagawa K; Takeda H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Aug; 32(4):187-93. PubMed ID: 23012886
[TBL] [Abstract][Full Text] [Related]
5. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
6. Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression.
Guscott M; Bristow LJ; Hadingham K; Rosahl TW; Beer MS; Stanton JA; Bromidge F; Owens AP; Huscroft I; Myers J; Rupniak NM; Patel S; Whiting PJ; Hutson PH; Fone KC; Biello SM; Kulagowski JJ; McAllister G
Neuropharmacology; 2005 Mar; 48(4):492-502. PubMed ID: 15755477
[TBL] [Abstract][Full Text] [Related]
7. Selective agonists for serotonin 7 (5-HT7) receptor and their applications in preclinical models: an overview.
Di Pilato P; Niso M; Adriani W; Romano E; Travaglini D; Berardi F; Colabufo NA; Perrone R; Laviola G; Lacivita E; Leopoldo M
Rev Neurosci; 2014; 25(3):401-15. PubMed ID: 24622785
[TBL] [Abstract][Full Text] [Related]
8. A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms.
Lovenberg TW; Baron BM; de Lecea L; Miller JD; Prosser RA; Rea MA; Foye PE; Racke M; Slone AL; Siegel BW
Neuron; 1993 Sep; 11(3):449-58. PubMed ID: 8398139
[TBL] [Abstract][Full Text] [Related]
9. Circadian rhythm phenotype of 5-HT7 receptor knockout mice: 5-HT and 8-OH-DPAT-induced phase advances of SCN neuronal firing.
Sprouse J; Li X; Stock J; McNeish J; Reynolds L
J Biol Rhythms; 2005 Apr; 20(2):122-31. PubMed ID: 15834109
[TBL] [Abstract][Full Text] [Related]
10. 5-HT7 receptors.
Thomas DR; Hagan JJ
Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):81-90. PubMed ID: 14965246
[TBL] [Abstract][Full Text] [Related]
11. A 5-HT(7) receptor-mediated depolarization in the anterodorsal thalamus. I. Pharmacological characterization.
Chapin EM; Andrade R
J Pharmacol Exp Ther; 2001 Apr; 297(1):395-402. PubMed ID: 11259568
[TBL] [Abstract][Full Text] [Related]
12. Characterization of putative 5-HT7 receptors mediating tachycardia in the cat.
Villalón CM; Heiligers JP; Centurión D; De Vries P; Saxena PR
Br J Pharmacol; 1997 Jul; 121(6):1187-95. PubMed ID: 9249256
[TBL] [Abstract][Full Text] [Related]
13. 5-HT(1A) and 5-HT(7) receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission.
Costa L; Trovato C; Musumeci SA; Catania MV; Ciranna L
Hippocampus; 2012 Apr; 22(4):790-801. PubMed ID: 21538661
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Dumuis A; Sebben M; Bockaert J
Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
[TBL] [Abstract][Full Text] [Related]
15. An mRNA expression analysis of stimulation and blockade of 5-HT7 receptors during memory consolidation.
Pérez-García G; Gonzalez-Espinosa C; Meneses A
Behav Brain Res; 2006 Apr; 169(1):83-92. PubMed ID: 16480781
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation.
Adham N; Zgombick JM; Bard J; Branchek TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):508-14. PubMed ID: 9808674
[TBL] [Abstract][Full Text] [Related]
17. A 5-HT(7) receptor-mediated depolarization in the anterodorsal thalamus. II. Involvement of the hyperpolarization-activated current I(h).
Chapin EM; Andrade R
J Pharmacol Exp Ther; 2001 Apr; 297(1):403-9. PubMed ID: 11259569
[TBL] [Abstract][Full Text] [Related]
18. Novel 2-aminotetralin and 3-aminochroman derivatives as selective serotonin 5-HT7 receptor agonists and antagonists.
Holmberg P; Sohn D; Leideborg R; Caldirola P; Zlatoidsky P; Hanson S; Mohell N; Rosqvist S; Nordvall G; Johansson AM; Johansson R
J Med Chem; 2004 Jul; 47(16):3927-30. PubMed ID: 15267230
[TBL] [Abstract][Full Text] [Related]
19. In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors.
Wesołowska A
Pol J Pharmacol; 2002; 54(4):327-41. PubMed ID: 12523486
[TBL] [Abstract][Full Text] [Related]
20. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.
Bonaventure P; Kelly L; Aluisio L; Shelton J; Lord B; Galici R; Miller K; Atack J; Lovenberg TW; Dugovic C
J Pharmacol Exp Ther; 2007 May; 321(2):690-8. PubMed ID: 17314195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
